Cargando…

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?

Worldwide, there is a shifting paradigm from immediate surgery with adjuvant treatment to a neoadjuvant approach for patients with resectable or borderline resectable pancreatic cancer (RPC or BRPC). Comparison of neoadjuvant and adjuvant studies is extremely difficult because of a great difference...

Descripción completa

Detalles Bibliográficos
Autores principales: Versteijne, Eva, de Hingh, Ignace H. J. T., Homs, Marjolein Y. V., Intven, Martijn P. W., Klaase, Joost M., van Santvoort, Hjalmar C., de Vos-Geelen, Judith, Wilmink, Johanna W., van Tienhoven, Geertjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882845/
https://www.ncbi.nlm.nih.gov/pubmed/35237500
http://dx.doi.org/10.3389/fonc.2021.744161